Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly

NCT00182091 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00182091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00182091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2004
Completion date
December 31, 2010
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly, growth hormone deficiency, pituitary disease